House Appropriations Committee Report Directs DEA, FDA to Tighten Enforcement on Psychoactive Hemp Products

A House Appropriations Committee report instructs the DEA and FDA to step up enforcement against unregulated hemp/cannabis products—particularly those containing psychoactive or controlled substances—that threaten consumer safety.

For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.